EUDA Health Holdings Limited
NASDAQ:EUDAMedical - Care Facilities
+$2.20 today
- Market cap
- $53.00M
- Beta
- 0.59
- P/E (TTM)
- -7.9
- EPS (TTM)
- -$1.79
Volume 0.04M
Average 0.02M
EUDA EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
EUDA Health Holdings LimitedNASDAQ: EUDA
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) remains negative
Q2 FY2026 EPS (Diluted) was -$0.16, compared with -$0.32 a year earlier. Trailing-twelve-month EPS (Diluted) was -$2.23.
Context
- EPS (Diluted) grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 1 analysts of $1.6 (+207.4%) for the fiscal year ending Dec 2026, a step up from the +84.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- -$0.16+2.2% QoQ
- Last fiscal yearDec 2025
- -$1.49+84.1% YoY
- LTMJun 2026
- -$2.23-98.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +50.6% | -185.7% | -236.3 pp |
| 1 year | +84.1% | +207.4% | +123.2 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- (1.49) USD
- Year-over-year change
- +84.1%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.49) | +84.1% |
| FY2024 | 2024-12-31 | (9.40) | -6.8% |
| FY2023 | 2023-12-31 | (8.80) | +78.7% |
| FY2022 | 2022-12-31 | (41.40) | -2313.9% |
| FY2021 | 2021-12-31 | 1.87 | — |
EPS (Diluted) vs competitors
How EUDA compares with its peers on the latest reported figures
- Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
- Its year-over-year change of -98.7% is the lowest of 8, against a peer median of +9.9%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $1 USD | -19.4% | -11.1% | |
| LTM Mar 2026 | -CA$0.09 CAD | +10.2% | — | |
| LTM Mar 2026 | -$0.41 USD | +23.6% | — | |
| LTM Mar 2026 | -$0.73 USD | +9.9% | — | |
| LTM Mar 2026 | -$1.74 USD | +5.4% | — | |
| LTM Jun 2026 | -$2.23 USD | -98.7% | — | |
| LTM Mar 2026 | -$4.41 USD | -86.1% | — | |
| LTM Mar 2026 | -$5.42 USD | +46.8% | — | |
| Peer median (excluding EUDA) | — | +9.9% | -11.1% | |
Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.56M | 3.76M | 3.71M | 4.01M | 6.82M |
| Cost of Revenue | 3.31M | 2.89M | 2.86M | 3.25M | 3.83M |
| Gross Profit | 1.25M | 870K | 842.08K | 762.16K | 2.99M |
| Gross Margin | 27.4% | 23.1% | 22.7% | 19.0% | 43.9% |
| Research & Development | 129.27K | 17.21K | 0 | 0 | 249 |
| Selling, General & Admin | 1.81M | 6.75M | 4.8M | 3.34M | 5.43M |
| Operating Expenses | 1.81M | 13.09M | 4.8M | 18.1M | 5.43M |
| Depreciation & Amortization | 264.1K | 172.02K | 119.35K | 173.22K | 406.48K |
| EBITDA | 1.34M | (24.64M) | (8.29M) | (17.42M) | (2.09M) |
| EBITDA Margin | 29.4% | -654.6% | -223.7% | -434.4% | -30.7% |
| Operating Income | (559.99K) | (5.72M) | (3.96M) | (17.34M) | (2.44M) |
| Operating Margin | -12.3% | -151.9% | -106.9% | -432.2% | -35.8% |
| Interest Income | 1.92M | 0 | 0 | 0 | 0 |
| Interest Expense | 127.13K | 93.78K | 23.23K | 44.89K | 228.62K |
| Other Income / Expenses | 2.23M | (19.21M) | (4.47M) | (307.38K) | (285.26K) |
| Income Before Tax | 1.67M | (24.93M) | (8.43M) | (17.64M) | (2.73M) |
| Pre-Tax Margin | 36.6% | -662.3% | -227.6% | -439.8% | -40.0% |
| Income Tax Expense | 46.49K | (20.79K) | 0 | (4.38K) | 41.94K |
| Net Income | 864.83K | (24.88M) | (10.04M) | (15.36M) | (2.77M) |
| Net Margin | 19.0% | -661.1% | -270.9% | -382.9% | -40.7% |
| EPS (Basic) | 1.87 | (41.40) | (8.80) | (9.40) | (1.49) |
| EPS (Diluted) | 1.87 | (41.40) | (8.80) | (9.40) | (1.49) |
| Weighted Avg Shares | 462.67K | 601.48K | 1.15M | 1.62M | 1.86M |
| Weighted Avg Shares (Diluted) | 462.67K | 601.48K | 1.15M | 1.62M | 1.86M |
EUDA Health Holdings Limited
NASDAQ:EUDA
Intrinsic Alpha fair value
Locked
Current Price
$17.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.